论文部分内容阅读
本文目的在于研究各期喉癌病人的机体非特异性体液因子保护反应,细胞免疫应答反应,并企图应用脾素液配合药物治疗,使免疫过程正常化。全部喉癌病人分为两组:第一组140名病人,因种种原因未进行免疫恢复治疗。第二组72名病
The purpose of this article is to study the non-specific humoral factor protection response and cellular immune response in patients with laryngeal cancer at different stages, and to attempt to normalize the immune process by applying spleen fluid with drugs. All patients with laryngeal cancer were divided into two groups: The first group of 140 patients had not been treated for immune recovery for various reasons. The second group of 72 patients